RP
GILD icon

Rowlandmiller & Partners’s Gilead Sciences GILD Stock Holding History

Rowlandmiller & Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.59M Buy
36,350
+4,400
+14% +$580K 0.84% 30
2026
Q1 		$4.45M Sell
31,950
-922
-3% -$129K 0.9% 30
2025
Q4 		$4.03M Buy
32,872
+1
+0% +$122 0.78% 31
2025
Q3 		$3.65M Sell
32,871
-970
-3% -$110K 0.72% 38
2025
Q2 		$3.75M Sell
33,841
-135
-0.4% -$14.4K 0.77% 36
2025
Q1 		$3.81M Buy
33,976
+1
+0% +$103 0.8% 35
2024
Q4 		$3.14M Buy
33,975
+42
+0.1% +$3.78K 0.66% 40
2024
Q3 		$2.84M Sell
33,933
-609
-2% -$46.5K 0.58% 47
2024
Q2 		$2.37M Sell
34,542
-6,004
-15% -$401K 0.52% 50
2024
Q1 		$2.97M Sell
40,546
-238
-0.6% -$18.3K 0.63% 44
2023
Q4 		$3.3M Sell
40,784
-330
-0.8% -$25.7K 0.76% 40
2023
Q3 		$3.08M Sell
41,114
-459
-1% -$35.3K 0.76% 39
2023
Q2 		$3.2M Sell
41,573
-176
-0.4% -$14K 0.76% 40
2023
Q1 		$3.46M Sell
41,749
-136
-0.3% -$11.3K 0.84% 37
2022
Q4 		$3.58M Sell
41,885
-5,025
-11% -$398K 0.89% 37
2022
Q3 		$2.89M Buy
46,910
+786
+2% +$49.6K 0.78% 38
2022
Q2 		$2.85M Buy
46,124
+1,257
+3% +$77.8K 0.73% 41
2022
Q1 		$2.67M Buy
44,867
+3,162
+8% +$202K 0.62% 47
2021
Q4 		$2.62M Buy
41,705
+15,412
+59% +$1.06M 0.59% 48
2021
Q3 		$2.02M Sell
26,293
-9,271
-26% -$651K 0.69% 41
2021
Q2 		$2.45M Buy
35,564
+479
+1% +$32K 0.6% 50
2021
Q1 		$2.27M Buy
35,085
+5,216
+17% +$336K 0.59% 48
2020
Q4 		$1.74M Buy
29,869
+4,155
+16% +$251K 0.5% 53
2020
Q3 		$1.92M Sell
25,714
-579
-2% -$40.2K 0.77% 39
2020
Q2 		$2.02M Buy
26,293
+579
+2% +$44.4K 0.69% 41
2020
Q1 		$1.92M Buy
25,714
+380
+1% +$26.3K 0.77% 39
2019
Q4 		$1.65M Hold
25,334
– – 0.51% 52
2019
Q3 		$1.61M Buy
25,334
+2,610
+11% +$171K 0.55% 50
2019
Q2 		$1.53M Buy
22,724
+8,111
+56% +$534K 0.53% 50
2019
Q1 		$950K Buy
14,613
+2,200
+18% +$146K 0.34% 60
2018
Q4 		$776K Buy
12,413
+790
+7% +$55.2K 0.31% 63
2018
Q3 		$897K Buy
11,623
+1,180
+11% +$89.1K 0.32% 59
2018
Q2 		$740K Buy
10,443
+1,552
+17% +$110K 0.29% 63
2018
Q1 		$672K Buy
8,891
+3,588
+68% +$285K 0.27% 65
2017
Q4 		$381K Hold
5,303
– – 0.15% 81
2017
Q3 		$428K Buy
5,303
+3,140
+145% +$240K 0.18% 75
2017
Q2 		$153K Buy
+2,163
New +$144K 0.06% 111
2016
Q2 		– Sell
-1,133
Closed -$104K – 122
2016
Q1 		$104K Buy
1,133
+81
+8% +$7.3K 0.05% 121
2015
Q4 		$103K Hold
1,052
– – 0.05% 122
2015
Q3 		$102K Hold
1,052
– – 0.05% 121
2015
Q2 		$123K Hold
1,052
– – 0.06% 123
2015
Q1 		$101K Sell
1,052
-100
-9% -$10.2K 0.05% 125
2014
Q4 		$109K Buy
+1,152
New +$119K 0.05% 120

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Rowlandmiller & Partners's GILD Position: Q2 2026 in Review

Rowlandmiller & Partners increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $580K and bringing the position to 36,350 shares worth $4.59M. The position accounts for 0.84% of the portfolio, ranked #30.

Rowlandmiller & Partners first reported a position in GILD in Q4 2014 and has held it in 43 quarters since. 642 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Rowlandmiller & Partners held 36,350 shares of Gilead Sciences worth $4.59M as of Q2 2026.
  • Rowlandmiller & Partners bought 4,400 Gilead Sciences shares in Q2 2026, an estimated $580K.
  • Gilead Sciences made up 0.84% of Rowlandmiller & Partners's portfolio in Q2 2026, its #30 holding.
  • Rowlandmiller & Partners first reported a position in Gilead Sciences in Q4 2014 and has held it in 43 quarters since.
  • 642 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.